AMENDMENT NO. 2 TO REVENUE INTEREST PURCHASE AGREEMENTRevenue Interest Purchase Agreement • April 26th, 2021 • Esperion Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2021 Company Industry JurisdictionThis Amendment No. 2 (this “Amendment”) is entered into by and among Esperion Therapeutics, Inc., a Delaware corporation (the “Company”), Eiger Partners II LP (“Purchaser”) and Eiger III SA LLC, as collateral agent and administrative agent for the Purchasers (“Purchaser Agent”), effective as of April 26, 2021 (the “Second Amendment Effective Date”).